Deals
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
L’Oréal and Galderma have signed a memorandum of understanding to collaborate on complementary research projects to discover ‘new avenues and accelerate innovation’ in the field of dermatology. L’Oreal has arranged to purchase a 10% stake in its partner.
Estee Lauder Companies taps a CFO; L’Oréal SA expands SkinCeuticals brand in Japan through Cutera partnership; IFF's Shanghai Creative Center operational by September; vegan hair care brand Naturaz expanding retail with seed funding; American Exchange Group acquires Indie Lee; and US men using skin care up 68% since 2022.
Through this exciting partnership and adoption of breakthrough technology, we are well-positioned to drive the creation of more sustainable and effective products that meet the demands of our consumers and fulfils our duty of care for the planet,” says L’Oréal Groupe’s Guive Balooch on the firm’s expanded partnership with Debut Biotechnology. More cosmetics news in brief.
The negotiated revision of the Classification, Labeling and Packaging (CLP) regulation met with industry approval in April, even if it just kicks the can down the road with regard to classification of more-than-one-constituent substances (MOCS). DSM-Firmenich announces partnerships with plants in mind, Symrise’s new CEO maintains growth targets, and more news in brief.
Procter & Gamble will feature more than 30 of its brands in Paris 2024 Olympic and Paralympic Games-inspired campaigns spotlighting “Everyday Champions” in its portfolio.
With NIVEA driving growth in its Consumer division, German firm Beiersdorf AG has signed a multi-year deal with Rubedo Life Sciences to develop anti-aging solutions and new products for the global market. More beauty business news, including L’Oreal, Inter Parfums, Galderma, and LVMH/Sephora sales updates.
Shiseido and Kao report China and travel retail were significant headwinds in 2023, though both expect smoother sailing ahead. More beauty news in brief.
Splitting off Avon as its own publicly traded company would unlock shareholder value and provide shareholders with greater visibility into the entities’ performance and potential, Natura says. Sephora sales fueled 20% reported growth in LVMH’s Selective Retailing business in 2023. More beauty news.
Share price’s recent ride doesn’t track with analysts’ regard for C&D’s results and outlook.
L’Oréal CEO Nicolas Hieronimus, a keynote speaker at the Consumer Electronics Show that kicked off in Las Vegas on 9 January, discussed product innovations that won it seven CES Innovation awards, including an infrared light hair-drying device that is less damaging to hair than conventional dryers and saves energy.
Natura says its sale of The Body Shop to international private equity group Aurelius – following its divestiture of Aesop to L’Oreal in a deal that closed in August – is another step toward simplifying operations and refocusing on strategic priorities. More cosmetics news.
Cosmo’s extraction technology harnesses the volatile fragrance molecules of flowers, fruits and other natural ingredients using only air, without the need for heating, cooling or chemical solvents used in conventional scent extraction, L’Oreal says. A tuberose extract is first in line for use in a perfume targeted for launch in 2024.
Clariant believes it can grow International Flavors & Fragrances’ cosmetic ingredients business, principally Lucas Meyer active ingredients, functional ingredients and delivery systems, from $100m in sales annually to $180m by 2028. IFF will use proceeds from that and other recent divestures to pay down debt.
The Cincinnati-based consumer goods giant embraces digital scent creation, partnering with Moodify to incorporate “the world’s first AI-based algorithmic malodor control” in its fragrance development program.
France's Pierre Fabre is enhancing its presence in the women's health market by taking a stake in dietary supplements and cosmetics firm MiYé.
The Embr Wave wristband provides instant hot-flash relief “at the touch of a button” using precisely calibrated cooling or warming sensations. Embr Labs and VICHY, which markets Neovadiol skin care formulated for peri- and post-menopausal skin, will promote each other's offerings across digital and social channels.
Vagisil and BioFilm’s Astroglide “demonstrate very high levels of brand awareness, brand loyalty, and repeat purchase, and continue to attract new and younger consumers into the category,” firms say.
“Cell-free biomanufacturing is not science fiction: it is here,” says L’Oreal’s Barbara Lavernos deputy chief executive officer in charge of research, innovation and technology, on the beauty giant’s investment in Debut Biotechnology, Inc. to drive development of sustainable, next-generation active ingredients for cosmetics. More news in brief.